C07D 417/00
Heterocyclic compounds containing two or more hetero rings, at least one ring
Official title: Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
C07D417/00 (Heterocyclic compounds containing two or more hetero rings, at least one ring) appears on 18,425 US grants and 21,220 published applications in this corpus.
Search patents in C07D- Granted patents
- 18,425
- Published applications
- 21,220
- Assignees
- 4,404
- Inventors
- 41,748
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 47 | 0 |
| 1977 | 47 | 0 |
| 1978 | 20 | 0 |
| 1979 | 11 | 0 |
| 1980 | 19 | 0 |
| 1981 | 19 | 0 |
| 1982 | 16 | 0 |
| 1983 | 33 | 0 |
| 1984 | 71 | 0 |
| 1985 | 96 | 0 |
| 1986 | 102 | 0 |
| 1987 | 137 | 0 |
| 1988 | 138 | 0 |
| 1989 | 173 | 0 |
| 1990 | 171 | 0 |
| 1991 | 195 | 0 |
| 1992 | 186 | 0 |
| 1993 | 229 | 0 |
| 1994 | 204 | 0 |
| 1995 | 204 | 0 |
| 1996 | 246 | 0 |
| 1997 | 321 | 0 |
| 1998 | 291 | 0 |
| 1999 | 287 | 0 |
| 2000 | 297 | 0 |
| 2001 | 335 | 66 |
| 2002 | 392 | 383 |
| 2003 | 383 | 635 |
| 2004 | 314 | 937 |
| 2005 | 344 | 858 |
| 2006 | 456 | 826 |
| 2007 | 480 | 850 |
| 2008 | 468 | 832 |
| 2009 | 561 | 987 |
| 2010 | 661 | 1139 |
| 2011 | 619 | 982 |
| 2012 | 776 | 890 |
| 2013 | 864 | 907 |
| 2014 | 903 | 1026 |
| 2015 | 883 | 966 |
| 2016 | 759 | 909 |
| 2017 | 799 | 819 |
| 2018 | 683 | 878 |
| 2019 | 702 | 846 |
| 2020 | 644 | 879 |
| 2021 | 543 | 723 |
| 2022 | 495 | 764 |
| 2023 | 448 | 1005 |
| 2024 | 453 | 836 |
| 2025 | 532 | 731 |
| 2026 | 368 | 546 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Double degraders and uses thereof6 Oct 2026US 12,753,172 B2Kymera Therapeutics, Inc.
- Polymorphic forms and formulations of leriglitazone8 Oct 2026US 2026/0306468 A1Minoryx Therapeutics S.L.
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Morpholino-subunit combinatorial library and method422US 5,506,337 AAntivirals Inc. · 1996
- Morpholino-subunit combinatorial library and method402US 5,698,685 AAntivirals Inc. · 1997
- Substituted unsymmetrical cyanine dyes with selected permeability384US 5,658,751 AMolecular Probes, Inc. · 1997
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995